Wilhelmus Cm Groenhuysen, Chief Operating Officer at NovoCure Ltd (NVCR), sold 7,708 shares at $137.55 ($1.1M) on 2021-03-04, disclosed to the SEC on 2021-03-08.
Open-market sale of $1.1M NVCR by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $137.55 | 3,854 | $530K | 50.0% |
| 2 | $137.55 | 3,854 | $530K | 50.0% |
| Total | $137.55 avg | 7,708 | $1.1M | 100% |
| Filing → |
| NVCR | SELL | 2023-09-05 | $6K | — | Filing → |
| NVCR | SELL | 2023-03-07 | $3.9M | — | Filing → |
| NVCR | SELL | 2023-03-06 | $183K | — | Filing → |